Exploring the Effectiveness of Digital Anti-stigma Therapy on Illness Perception and Perceived Stigma in Patients With Schizophrenia and Their Primary Caregivers
NCT Number: NCT06563752
Status: NOT_YET_RECRUITING
Study Type: INTERVENTIONAL
Phases: NA
Conditions: Schizophrenia
Interventions: OTHER: Participants will use 3D glasses to view VR educational information|OTHER: routine care
Sponsor: National Yang Ming Chiao Tung University
Sex: ALL
Age: ADULT, OLDER_ADULT
Enrollment: 360
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Start Date: 2024-10
Completion Date: 2027-12
Locations: National Yang Ming Chiao Tung University, Taipei, 112304, Taiwan

Summary:
This study aims to investigate the relationship between illness insight, self-stigma in patients with schizophrenia, and the awareness and associated stigma experienced by their families, as well as the predictors of these factors. The study will use information technology strategies for educational purposes, specifically employing 3D glasses for delivering this education. The goal is to develop a disease adaptation program that involves both patients and their families, helping to enhance disease awareness and improve stigma experiences.

Primary Outcome Measures: Positive and Negative Syndrome Scale, This scale primarily assesses the severity of psychiatric disorders and was originally developed by Kay et al. (1987). It includes three dimensions: positive symptoms, negative symptoms, and general psychopathology, with a total of 30 items., The assessment will be conducted three times: before the intervention, immediately after the intervention, and three months after the intervention.|The Schedule for the Assessment of Insight, This is a semi-structured interview questionnaire developed by David (1990), primarily used to assess illness insight and perceptions of the illness in psychiatric disorders. It includes three aspects: illness awareness, the importance of treatment, and disease recognition, with a total of 7 items., The assessment will be conducted three times: before the intervention, immediately after the intervention, and three months after the intervention.|Internalized Stigma of Mental Illness, This scale primarily measures the subjective self-stigma experienced by individuals with mental illness and was developed in collaboration with patients. It includes 29 items across five dimensions: alienation, stereotype endorsement, perceived discrimination, social withdrawal, and anti-stigma coping ability., The assessment will be conducted three times: before the intervention, immediately after the intervention, and three months after the intervention.|Medication Adherence Rating Scale, This self-report scale assesses patients' medication attitudes and adherence behaviors over the past week. It consists of 10 true/false questions, with scores ranging from 1 to 7 indicating poor adherence and 8 to 10 indicating good adherence., The assessment will be conducted three times: before the intervention, immediately after the intervention, and three months after the intervention.|Drug Attitude Inventory-10, This is a self-report scale primarily used to assess patients' attitudes towards medication., The assessment will be conducted three times: before the intervention, immediately after the intervention, and three months after the intervention.|Illness Perception Questionnaire-Revised Version for Families of Patients with Schizophrenia, This is a survey questionnaire designed to assess illness awareness among the family members of individuals with schizophrenia. It includes 38 items across 7 dimensions, evaluating participants' knowledge about schizophrenia and its management, causes, prevalence, prognosis, and treatment., The assessment will be conducted three times: before the intervention, immediately after the intervention, and three months after the intervention.|Affiliate Stigma Scale, The primary purpose is to assess the caregiver's perception of internalized stigma. The scale consists of 22 items, covering three aspects: cognition, emotion, and behavior., The assessment will be conducted three times: before the intervention, immediately after the intervention, and three months after the intervention.|Caregiver Burden Scale, The main purpose is to assess the burden level of caregivers of psychiatric patients. The scale contains 18 questions, measuring the actual problems and feelings that arise from caregiving. The scale includes five subdimensions., The assessment will be conducted three times: before the intervention, immediately after the intervention, and three months after the intervention.|World Health Organisation- Five Well-Being Index, To assess the perception of Well-Being over the past two weeks., The assessment will be conducted three times: before the intervention, immediately after the intervention, and three months after the intervention.|Multidimensional Scale of Perceived Social Support, To assess social support from different sources. The scale consists of 12 items across three dimensions: family, friends, and significant others., The assessment will be conducted three times: before the intervention, immediately after the intervention, and three months after the intervention.